These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29027)

  • 1. Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media.
    Perea EJ; Aznar J; Garcia-Iglesias MC; Borobio MV
    J Antimicrob Chemother; 1978 Jul; 4(B):55-60. PubMed ID: 29027
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.
    Goldstein EJ; Citron DM; Cherubin CE
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1868-74. PubMed ID: 1952860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of differences in media and methods on MIC values for anaerobes.
    Wexler HM; Finegold SM
    Hosp Pract (Off Ed); 1990 Oct; 25 Suppl 4():24-30. PubMed ID: 2120269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteroides fragilis and HR 756.
    Wise R
    J Antimicrob Chemother; 1979 Jan; 5(1):115-6. PubMed ID: 762000
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in susceptibility testing of anaerobes.
    Aldridge KE
    Clin Ther; 1987; 10 Suppl A():2-11. PubMed ID: 3319171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of anaerobic bacteria to cofoxitin and related compounds.
    Bach VT; Roy I; Thadepalli H
    Antimicrob Agents Chemother; 1977 May; 11(5):912-3. PubMed ID: 879743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
    Wexler HM; Reeves D; Finegold SM
    Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.
    Sutter VL; Kwok YY
    Antimicrob Agents Chemother; 1981 Dec; 20(6):723-5. PubMed ID: 6459765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria.
    Shadomy S; Mayhall CG; Apollo E
    J Infect Dis; 1977 Nov; 136(5):697-700. PubMed ID: 915342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.
    Sevillano D; Aguilar L; Alou L; Giménez MJ; Cafini F; González N; Prieto J
    Rev Esp Quimioter; 2013 Sep; 26(3):220-5. PubMed ID: 24080888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobes to cefoxitin sodium and cephalothin.
    Sutter VL; Oberhammer I; Kwok YY; Finegold SM
    J Antimicrob Chemother; 1978 Jul; 4(B):41-6. PubMed ID: 690025
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.
    Bansal MB; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(4):237-43. PubMed ID: 6744975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative in vitro activity of 4 cephalosporins on Bacteroides fragilis].
    Castillo AM; Fernández-Crehuet M; Ocete MD; Liébana JJ; Cueto A; Maroto MC; Piédrola MG
    Med Clin (Barc); 1986 Apr; 86(15):624-6. PubMed ID: 3724274
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M; Avanzini P; Lecchini R; Bigi M; Chezzi C
    Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
    Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
    Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.